Wedbush Securities Inc Gilead Sciences, Inc. Transaction History

Wedbush Securities Inc

$2.8 Billion
Q2 2024

A detailed history of Wedbush Securities Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wedbush Securities Inc holds 28,828 shares of GILD stock, worth $2.54 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

28,828

Previous 30,040 4.03%

Holding current value

$2.54 Million

Previous $2.2 Million 10.09%

% of portfolio

0.07%

Previous 0.08%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$63.15 - $72.88 $76,537 - $88,330	-1,212 Reduced 4.03%	28,828 $1.98 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $753,665 - $919,076	10,529 Added 53.96%	30,040 $2.2 Million
Q4 2023 Feb 12, 2024	SELL	$73.27 - $83.09 $30,187 - $34,233	-412 Reduced 2.07%	19,511 $1.58 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $112,536 - $122,779	1,522 Added 8.27%	19,923 $1.49 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $32,608 - $37,194	-429 Reduced 2.28%	18,401 $1.42 Million
Q1 2023 May 09, 2023	SELL	$77.31 - $88.08 $108,852 - $124,016	-1,408 Reduced 6.96%	18,830 $1.56 Million
Q4 2022 Jan 31, 2023	SELL	$62.32 - $89.47 $745,534 - $1.07 Million	-11,963 Reduced 37.15%	20,238 $1.74 Million
Q3 2022 Oct 18, 2022	BUY	$59.54 - $68.01 $72,102 - $82,360	1,211 Added 3.91%	32,201 $1.99 Million
Q2 2022 Jul 21, 2022	BUY	$57.72 - $65.01 $5,829 - $6,566	101 Added 0.33%	30,990 $1.92 Million
Q1 2022 Apr 19, 2022	SELL	$57.92 - $72.58 $233,823 - $293,005	-4,037 Reduced 11.56%	30,889 $1.84 Million
Q4 2021 Jan 13, 2022	SELL	$64.88 - $73.64 $15,246 - $17,305	-235 Reduced 0.67%	34,926 $2.54 Million
Q3 2021 Oct 08, 2021	SELL	$67.69 - $73.03 $187,772 - $202,585	-2,774 Reduced 7.31%	35,161 $2.46 Million
Q2 2021 Jul 27, 2021	BUY	$63.47 - $69.35 $29,323 - $32,039	462 Added 1.23%	37,935 $2.61 Million
Q1 2021 Apr 26, 2021	BUY	$60.0 - $68.46 $203,400 - $232,079	3,390 Added 9.95%	37,473 $2.42 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $13,029 - $14,846	230 Added 0.68%	34,083 $1.99 Million
Q3 2020 Oct 20, 2020	SELL	$62.1 - $78.08 $170,712 - $214,641	-2,749 Reduced 7.51%	33,853 $2.14 Million
Q2 2020 Jul 16, 2020	BUY	$72.34 - $84.0 $448,508 - $520,800	6,200 Added 20.39%	36,602 $2.82 Million
Q1 2020 Apr 17, 2020	BUY	$62.63 - $80.22 $403,525 - $516,857	6,443 Added 26.89%	30,402 $2.27 Million
Q4 2019 Jan 16, 2020	BUY	$61.62 - $67.78 $222,386 - $244,618	3,609 Added 17.73%	23,959 $1.56 Million
Q3 2019 Oct 17, 2019	SELL	$62.51 - $69.0 $119,956 - $132,411	-1,919 Reduced 8.62%	20,350 $1.29 Million
Q2 2019 Aug 01, 2019	SELL	$61.87 - $69.38 $618,885 - $694,008	-10,003 Reduced 31.0%	22,269 $1.5 Million
Q1 2019 Apr 17, 2019	SELL	$62.53 - $70.05 $1.16 Million - $1.3 Million	-18,615 Reduced 36.58%	32,272 $2.1 Million
Q4 2018 Jan 31, 2019	SELL	$60.54 - $79.0 $344,593 - $449,668	-5,692 Reduced 10.06%	50,887 $3.18 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $4,989 - $5,524	70 Added 0.12%	56,579 $4.37 Million
Q2 2018 Aug 03, 2018	SELL	$64.88 - $75.68 $380,650 - $444,014	-5,867 Reduced 9.41%	56,509 $4 Million
Q1 2018 May 01, 2018	SELL	$72.84 - $88.8 $198,561 - $242,068	-2,726 Reduced 4.19%	62,376 $4.7 Million
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $46,959 - $55,123	660 Added 1.02%	65,102 $4.66 Million
Q3 2017 Oct 31, 2017	BUY	$72.11 - $85.47 $4.65 Million - $5.51 Million	64,442	64,442 $5.22 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.

Account

Wedbush Securities Inc Gilead Sciences, Inc. Transaction History